Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Entasis Therapeutics Holdings Inc. (ETTX)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Entasis Therapeutics Holdings Inc. since year 2005.
Table 2 shows the detailed insider transactions of Entasis Therapeutics Holdings Inc. since 2005.
The reporting company's ticker symbol is ETTX. The reporting company's CIK number is 1724344.
The total value of stock buying since 2005 is $64,061,640.
The total value of stock sales since 2005 is $250,000.
The total value of stock option exercises since 2005 is $75,432.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-09||Heron Patrick J (10% Owner)||Sale||50,000||5.00||250,000|
|2018-12-21||Tommasi Ruben (Chief Scientific Officer)||Option Ex||22,024||3.42||75,432|
|2018-09-28||Pivotal Bioventure Partners Fund I U.g.p., Ltd (10% Owner)||Buy||337,724||15.00||5,065,860|
|2018-09-28||Fhm Life Sciences Viii, L.p. (10% Owner)||Buy||375,887||15.00||5,638,305|
|2018-09-28||Preston Heather (Director)||Buy||337,724||15.00||5,065,860|
|2018-09-28||Novo Holdings A/s (10% Owner)||Buy||1,089,835||15.00||16,347,525|
|2018-09-28||Topper James N (Director)||Buy||375,887||15.00||5,638,305|
|2018-09-28||Wheeler Kurt (10% Owner)||Buy||453,395||15.00||6,800,925|
|2018-09-28||Galakatos Nicholas (Director)||Buy||453,395||15.00||6,800,925|
|2018-09-28||Powell Michael (10% Owner)||Buy||337,724||15.00||5,065,860|
|2018-09-28||Coulter James G||Buy||262,539||15.00||3,938,085|
|2018-09-28||Astrazeneca Ab (10% Owner)||Buy||246,666||15.00||3,699,990|
Insider trading activities including stock purchases, stock sales, and option exercises of ETTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Entasis Therapeutics Holdings Inc. (symbol ETTX, CIK number 1724344) see the Securities and Exchange Commission (SEC) website.